Ligand validation:6BTZ

O4B: 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE

O4B is a Ligand Of Interest in 6BTZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BTZ_O4B_A_1705	41%	69%	0.17	0.884	0.62	0.56	-	-	3	0	100%	1
6BTZ_O4B_D_1703	30%	69%	0.215	0.878	0.62	0.57	-	-	2	0	100%	1
6BTZ_O4B_C_1706	22%	68%	0.225	0.84	0.65	0.59	-	-	1	0	100%	1
6BTZ_O4B_B_1706	22%	67%	0.22	0.833	0.71	0.55	-	-	3	0	100%	1
6BTZ_O4B_D_1704	13%	68%	0.275	0.818	0.66	0.57	-	-	9	0	100%	0.833
6BTZ_O4B_A_1706	8%	65%	0.312	0.779	0.73	0.61	-	-	6	0	100%	0.833
6BTY_O4B_B_1701	36%	59%	0.181	0.874	0.87	0.7	-	-	0	0	100%	1
6BU0_O4B_C_1703	5%	74%	0.423	0.844	0.57	0.43	-	-	2	0	100%	1
7JY1_O4B_B_203	95%	96%	0.067	0.972	0.16	0.2	-	-	0	0	100%	1
3WUR_O4B_B_202	94%	44%	0.067	0.964	1.23	0.96	1	1	0	0	100%	1
5ZW2_O4B_A_503	92%	64%	0.08	0.969	0.59	0.78	-	-	0	0	100%	1
7JY3_O4B_B_203	91%	97%	0.073	0.959	0.16	0.17	-	-	0	0	100%	1
6AF6_O4B_A_503	90%	72%	0.084	0.965	0.63	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.